Search

Your search keyword '"Eklund, Martin"' showing total 214 results

Search Constraints

Start Over You searched for: Author "Eklund, Martin" Remove constraint Author: "Eklund, Martin" Database OAIster Remove constraint Database: OAIster
214 results on '"Eklund, Martin"'

Search Results

1. Operative versus Nonoperative Treatment of Proximal Hamstring Avulsions

2. Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading

3. Differences and similarities in false interpretations by AI CAD and radiologists in screening mammography

4. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

5. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy

6. Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria

7. Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study

8. Reconsidering evaluation practices in modular systems: On the propagation of errors in MRI prostate cancer detection

9. Leveraging multi-view data without annotations for prostate MRI segmentation: A contrastive approach

10. Prostate Age Gap (PAG): An MRI surrogate marker of aging for prostate cancer detection

11. Physical Color Calibration of Digital Pathology Scanners for Robust Artificial Intelligence Assisted Cancer Diagnosis

12. Response to Carter et al.

13. Response to Carter et al.

14. Artificial intelligence for diagnosis and Gleason grading of prostate cancer : the PANDA challenge

15. A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines : Results from a Prospective Population-based Screening Study

16. I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.

17. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

18. Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

19. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

20. Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

21. Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

22. Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

23. Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

24. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

25. Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

26. Artificial intelligence for diagnosis and Gleason grading of prostate cancer : the PANDA challenge

27. Artificial intelligence for diagnosis and Gleason grading of prostate cancer : the PANDA challenge

28. I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.

29. Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

30. Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

31. Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

32. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

33. Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

34. Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

35. A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer.

36. Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

37. Artificial intelligence for diagnosis and Gleason grading of prostate cancer : the PANDA challenge

38. Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

39. A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines : Results from a Prospective Population-based Screening Study

40. Artificial intelligence for diagnosis and Gleason grading of prostate cancer : the PANDA challenge

41. External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort

42. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

43. Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

44. Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

45. Artificial intelligence for diagnosis and Gleason grading of prostate cancer : the PANDA challenge

46. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists

47. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists

48. Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM)

49. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

50. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

Catalog

Books, media, physical & digital resources